Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Contemporary clinical risk stratification schemata for predicting stroke and thromboembolism (TE) in patients with atrial fibrillation (AF) are largely derived from risk factors identified from trial cohorts. Thus, many potential risk factors have not been included. METHODS: We refined the 2006 Birmingham/National Institute for Health and Clinical Excellence (NICE) stroke risk stratification schema into a risk factor-based approach by reclassifying and/or incorporating additional new risk factors where relevant. This schema was then compared with existing stroke risk stratification schema in a real-world cohort of patients with AF (n = 1,084) from the Euro Heart Survey for AF. RESULTS: Risk categorization differed widely between the different schemes compared. Patients classified as high risk ranged from 10.2% with the Framingham schema to 75.7% with the Birmingham 2009 schema. The classic CHADS(2) (Congestive heart failure, Hypertension, Age > 75, Diabetes, prior Stroke/transient ischemic attack) schema categorized the largest proportion (61.9%) into the intermediate-risk strata, whereas the Birmingham 2009 schema classified 15.1% into this category. The Birmingham 2009 schema classified only 9.2% as low risk, whereas the Framingham scheme categorized 48.3% as low risk. Calculated C-statistics suggested modest predictive value of all schema for TE. The Birmingham 2009 schema fared marginally better (C-statistic, 0.606) than CHADS(2). However, those classified as low risk by the Birmingham 2009 and NICE schema were truly low risk with no TE events recorded, whereas TE events occurred in 1.4% of low-risk CHADS(2) subjects. When expressed as a scoring system, the Birmingham 2009 schema (CHA(2)DS(2)-VASc acronym) showed an increase in TE rate with increasing scores (P value for trend = .003). CONCLUSIONS: Our novel, simple stroke risk stratification schema, based on a risk factor approach, provides some improvement in predictive value for TE over the CHADS(2) schema, with low event rates in low-risk subjects and the classification of only a small proportion of subjects into the intermediate-risk category. This schema could improve our approach to stroke risk stratification in patients with AF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, diabetes may not be a significant risk factor for stroke in the elderly.620”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [620]
Experimental — accuracy not yet measuredIn the citing paper
“while patients with stroke risk factors (i.e.CHA 2 DS 2 -VASc score of 1 or more for men, and 2 or more for women) are likely to benefit from OAC.”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [368]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-12-200706190-00007 · Cited by 4,793
(1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420130036007 · Cited by 2,071
Mant, J., Hobbs, F. R., Fletcher, K., Roalfe, A., Fitzmaurice, D., Lip, G. Y., & Murray, E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61233-1 · Cited by 1,556
Self-citationBelch, J., MacCuish, A., Campbell, I., Cobbe, S., Taylor, R., Prescott, R., Lee, R., Bancroft, J., MacEwan, S., Shepherd, J., et al. (2008) · BMJ · doi:10.1136/bmj.a1840 · Cited by 977
Connolly, S. J., Pogue, J., Eikelboom, J., Flaker, G., Commerford, P., Franzosi, M. G., Healey, J. S., & Yusuf, S. (2008) · Circulation · doi:10.1161/circulationaha.107.750000 · Cited by 870
Wang, T. J., Massaro, J. M., Levy, D., Vasan, R. S., Wolf, P. A., D'Agostino, R. B., Larson, M. G., Kannel, W. B., & Benjamin, E. J. (2003) · JAMA · doi:10.1001/jama.290.8.1049 · Cited by 780
Antithrombotic Therapy in Atrial Fibrillation
Singer, D. E., Albers, G. W., Dalen, J. E., Fang, M. C., Go, A. S., Halperin, J. L., Lip, G. Y. H., & Manning, W. J. (2008) · Chest · doi:10.1378/chest.08-0678 · Cited by 751
Self-citationGage, B. F., van Walraven, C., Pearce, L., Hart, R. G., Koudstaal, P. J., Boode, B. S. P., & Petersen, P. (2004) · Circulation · doi:10.1161/01.cir.0000145172.55640.93 · Cited by 749
Cited by
Items 901–1,000 of 1,020
Su, X., Yan, B., Wang, L., Lv, J., Cheng, H., & Chen, Y. (2021) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2021.02.328 · Cited by 56
Izzy, M. J., Fortune, B. E., Serper, M., Bhave, N. M., deLemos, A. S., Gallegos-Orozco, J. F., Guerrero-Miranda, C. Y., Hall, S. A., Harinstein, M. E., Karas, M. G., et al. (2022) · American Journal of Transplantation · doi:10.1111/ajt.17049 · Cited by 56
Imberti, J. F., Mei, D. A., Vitolo, M., Bonini, N., Proietti, M., Potpara, T., Lip, G. Y. H., & Boriani, G. (2022) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2022.04.023 · Cited by 56
Self-citationChao, T., Liu, C., Chen, S., Wang, K.-L., Lin, Y.-J., Chang, S., Lo, L.-W., Hu, Y.-F., Tuan, T.-C., Chen, T.-J., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.11.011 · Cited by 56
McMurray, J. J. V., Adamopoulos, S. N., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G. S., Fonseca, C., Sánchez, M. Á. G., et al. (2012) · Revista Española de Cardiología · doi:10.1016/j.recesp.2012.08.003 · Cited by 56
Self-citationProvidencia, R. A., Trigo, J., Paiva, L., & Barra, S. (2013) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2013.05.010 · Cited by 56
Scheuermeyer, F. X., Innes, G. D., Pourvali, R., DeWitt, C., Grafstein, E., Heslop, C., MacPhee, J., Ward, J., Heilbron, B. G., McGrath, L., et al. (2013) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2013.04.004 · Cited by 56
Sandhu, R. K., Hohnloser, S. H., Pfeffer, M. A., Yuan, F., Hart, R. G., Yusuf, S., Connolly, S. J., McAlister, F. A., & Healey, J. S. (2015) · Stroke · doi:10.1161/strokeaha.114.007140 · Cited by 57
Fuentes, B., Gállego, J., Gil-Núñez, A., Morales, A., Purroy, F. F., Roquer, J., Segura, T., Tejada, J., Lago, A. P., Díez‐Tejedor, E., et al. (2011) · Neurología · doi:10.1016/j.nrl.2011.06.002 · Cited by 57
Wisløff, T. F., Hagen, G., & Klemp, M. (2014) · PharmacoEconomics · doi:10.1007/s40273-014-0152-z · Cited by 56
Clua‐Espuny, J. L., Lechuga-Durán, Í., Bosch, R., Roso‐Llorach, A., Panisello-Tafalla, A., Lucas-Noll, J., López, C., Queralt-Tomas, L., Giménez-García, E., González-Rojas, N., et al. (2013) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.03.003 · Cited by 57
Shavadia, J., Yonga, G., Mwanzi, S., Jinah, A., Moriasi, A., & Otieno, H. (2013) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2012-064 · Cited by 56
Vinereanu, D., Stevens, S. R., Alexander, J. H., Al‐Khatib, S. M., Avezum, Á., Bahit, M. C., Granger, C. B., Lópes, R. D., Halvorsen, S., Hanna, M., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv447 · Cited by 56
Lópes, R. D., Rao, M. P., Simon, D. N., Thomas, L. E., Ansell, J., Fonarow, G. C., Gersh, B. J., Go, A. S., Hylek, E. M., Kowey, P. R., et al. (2016) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.12.026 · Cited by 57
The World Heart Federation Roadmap for Nonvalvular Atrial Fibrillation
Murphy, A., Banerjee, A., BREITHARDT, G. E., Camm, A. J., Commerford, P., Freedman, B., González-Hermosillo, J. A., Halperin, J. L., Lau, C., Perel, P., et al. (2017) · Global Heart · doi:10.1016/j.gheart.2017.01.015 · Cited by 56
Rivera‐Caravaca, J. M., Roldán, V., Esteve‐Pastor, M. A., Valdés, M., Vicente, V., Lip, G. Y. H., & Marín, F. R. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006490 · Cited by 56
Self-citationIncidence, Trends, and Predictors of Ischemic Stroke 30 Days After an Acute Myocardial Infarction
Kajermo, U., Ulvenstam, A., Modica, A., Jernberg, T., & Mooe, T. (2014) · Stroke · doi:10.1161/strokeaha.113.001963 · Cited by 58
Stroke Risk Before and After Central Retinal Artery Occlusion in a US Cohort
Chodnicki, K. D., Pulido, J. S., Hodge, D. O., Klaas, J. P., & Chen, J. J.-W. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.10.018 · Cited by 56
Hsu, C., Liu, C., Tain, Y., Kuo, C.-Y., & Lin, Y.-C. (2020) · Journal of Medical Internet Research · doi:10.2196/16903 · Cited by 56
GARFIELD-AF: A Worldwide Prospective Registry of Patients With Atrial Fibrillation at Risk of Stroke
Bassand, J., Apenteng, P. N., Atar, D., Camm, A. J., Cools, F. J. S., Corbalan, R. L., Fitzmaurice, D. A., Fox, K. A. A., Goto, S., Haas, S. K., et al. (2020) · Future Cardiology · doi:10.2217/fca-2020-0014 · Cited by 56
Atrial Fibrillation and Heart Failure
Ariyaratnam, J., Lau, D. H., Sanders, P., & Kalman, J. M. (2021) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2020.11.004 · Cited by 56
Benz, A. P., Hijazi, Z., Lindbäck, J., Connolly, S. J., Eikelboom, J. W., Oldgren, J., Siegbahn, A. G., & Wallentin, L. C. (2021) · Circulation · doi:10.1161/circulationaha.120.053100 · Cited by 56
Yiin, G. S. C., Howard, D. P. J., Paul, N. L. M., Li, L., Mehta, Z., & Rothwell, P. M. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-311947 · Cited by 56
Biancari, F., Mahar, M. A. A., & Kangasniemi, O.-P. (2012) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2012.11.004 · Cited by 56
Anticoagulation in adults with congenital heart disease: The who, the when and the how?
Jensen, A. S., Idorn, L., Nørager, B., Vejlstrup, N. G., & Søndergaard, L. (2014) · Heart · doi:10.1136/heartjnl-2014-305576 · Cited by 56
Chang, H., Chan, Y., Kuo, L., & Chao, T. (2025) · Thrombosis and Haemostasis · doi:10.1055/a-2595-5575 · Cited by 55
Prevalence of Peripheral Artery Disease by Abnormal Ankle-Brachial Index in Atrial Fibrillation
Violi, F., Davì, G., Hiatt, W. R., Lip, G. Y. H., Corazza, G. R., Perticone, F., Proietti, M., Pignatelli, P., Vestri, A. R., & Basili, S. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.07.035 · Cited by 55
Self-citationStroke prevention in elderly patients with atrial fibrillation: challenges for anticoagulation
Sinnaeve, P., Brueckmann, M., Clemens, A., Oldgren, J., Eikelboom, J. W., & Healey, J. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02464.x · Cited by 57
Drabik, L., Wołkow, P. P., & Undas, A. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2015.05.028 · Cited by 56
Disertori, M., Franzosi, M. G., Barlera, S., Cosmi, F., Quintarelli, S., Favero, C., Cappellini, G., Fabbri, G., Maggioni, A. P., Staszewsky, L. I., et al. (2013) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-13-28 · Cited by 55
Annoni, G., & Mazzola, P. (2016) · 老年心脏病学杂志:英文版 · doi:10.11909/j.issn.1671-5411.2016.03.010 · Cited by 55
Diabetes mellitus and hypertension: a dual threat
Oktay, A. A., Aktürk, H. K., & Jahangir, E. (2016) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000297 · Cited by 55
Age- and sex-specific analysis of patients with embolic stroke of undetermined source
Ntaios, G., Lip, G. Y. H., Vemmos, K. N., Korompoki, E., Manios, E. D., Vemmou, A., Rodríguez-Campello, A., Cuadrado‐Godia, E., Roquer, J., Arnao, V., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004199 · Cited by 55
Self-citationBleeding Risk Scores in Atrial Fibrillation and Venous Thromboembolism
Zulkifly, H. H., Lip, G. Y. H., & Lane, D. A. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.06.058 · Cited by 55
Self-citationCallizo, J., Feltgen, N., Ammermann, A., Ganser, J., Bemme, S., Bertelmann, T., Pfeiffer, S., Duvinage, A., Gröschel, K., Hoerauf, H., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181766 · Cited by 55
Brown, J. D., Shewale, A. R., & Talbert, J. (2017) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2017.23.9.958 · Cited by 55
Lubitz, S. A., Khurshid, S. S., Weng, L.-C. C., Doros, G. D., Keach, J. W., Gao, Q., Gehi, A. K., Hsu, J. C., Reynolds, M. R., Turakhia, M. P., et al. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.03.003 · Cited by 55
Lewis, W. R., Piccini, J. P., Turakhia, M. P., Curtis, A. B., Fang, M. C., Suter, R. E., Page, R. L., II, & Fonarow, G. C. (2014) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.114.001263 · Cited by 56
Risk stratification for stroke in atrial fibrillation: a critique
Killu, A. M., Granger, C. B., & Gersh, B. J. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy731 · Cited by 56
Paschke, L. M., Klimke, K., Altiner, A., von Stillfried, D., & Schulz, M. (2020) · BMC Medicine · doi:10.1186/s12916-020-01695-7 · Cited by 55
Population Trends in All‐Cause Mortality and Cause Specific–Death With Incident Atrial Fibrillation
Singh, S. M., Abdel-Qadir, H. M., Pang, A., Fang, J., Koh, M., Dorian, P., Wijeysundera, H. C., & Ko, D. T. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.016810 · Cited by 55
Taniguchi, H., Takata, T., Takechi, M., Furukawa, A., Iwasawa, J., Kawamura, A., Taniguchi, T., & Tamura, Y. (2021) · International Heart Journal · doi:10.1536/ihj.21-094 · Cited by 55
Willens, H. J., Gómez-Marín, O., Nelson, K. H., DeNicco, A., & Moscucci, M. M. (2012) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2012.11.002 · Cited by 56
Imaging and biophysical modelling of thrombogenic mechanisms in atrial fibrillation and stroke
Qureshi, A., Lip, G. Y. H., Nordsletten, D., Williams, S. E., Aslanidi, O. V., & de Vecchi, A. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1074562 · Cited by 54
Self-citationPhysician's Fear of Anticoagulant Therapy in Nonvalvular Atrial Fibrillation
Sen, S., & Dahlberg, K. W. (2014) · The American Journal of the Medical Sciences · doi:10.1097/maj.0000000000000349 · Cited by 54
Saliba, W., Barnett‐Griness, O., Elias, M. S., & Rennert, G. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.01.025 · Cited by 55
The Association Between Red Cell Distribution Width and Stroke in Patients with Atrial Fibrillation
Saliba, W., Barnett‐Griness, O., Elias, M. S., & Rennert, G. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.09.020 · Cited by 56
Hsu, J. C., Chan, P. S.-F., Tang, F., Maddox, T. M., & Marcus, G. M. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.11.035 · Cited by 54
Biomarkers in atrial fibrillation: an overview
Vilchez, J. A., Roldán, V., Hernández‐Romero, D., Valdés, M., Lip, G. Y. H., & Marín, F. R. (2013) · International Journal of Clinical Practice · doi:10.1111/ijcp.12304 · Cited by 56
Self-citationNg, K. H., Hart, R. G., & Eikelboom, J. W. (2013) · Cardiology and Therapy · doi:10.1007/s40119-013-0019-y · Cited by 54
Macle, L., Cairns, J. A., Andrade, J. G., Mitchell, L. B., Nattel, S., Verma, A., Verma, A., Macle, L., Andrade, J. G., Atzema, C. L., et al. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.06.005 · Cited by 55
Ranolazine for rhythm control in atrial fibrillation: A systematic review and meta-analysis
Guerra, F., Romandini, A., Barbarossa, A., Belardinelli, L., & Capucci, A. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.11.103 · Cited by 54
Amara, W., Montagnier, C., Cheggour, S., Boursier, M., Gully, C., BARNAY, C., Georger, F., Deplagne, A., Fromentin, S., Młotek, M., et al. (2017) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.13062 · Cited by 57
Rivaroxaban for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation and Active Cancer
Laube, E., Yu, A. F., Gupta, D., Miao, Y., Samedy, P., Wills, J., Harnicar, S. J., Soff, G. A., & Mantha, S. H. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.04.009 · Cited by 54
Persistence With Dabigatran Therapy at 2 Years in Patients With Atrial Fibrillation
Paquette, M., França, L. R., Teutsch, C., Diener, H., Lu, S., Dubner, S., Sheng, C., Rothman, K. J., Zint, K., Halperin, J. L., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.07.793 · Cited by 54
Self-citationRodríguez-Bernal, C. L., Peiró, S., Hurtado, I., García‐Sempere, A., & Sanfélix‐Gimeno, G. (2018) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2018.24.5.440 · Cited by 54
Wang, C., Wu, V. C., Chang, K., Tu, H., Kuo, C., Huang, Y., Chu, P., Kuo, C.-C., & Chang, S. (2019) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvz035 · Cited by 54
Wetmore, J. B., Roetker, N. S., Yan, H., Reyes, J. L., & Herzog, C. A. (2020) · Stroke · doi:10.1161/strokeaha.120.028934 · Cited by 49
Himmelreich, J. C. L., Lucassen, W. A. M., Harskamp, R. E., Aussems, C., van Weert, H. C. P. M., & Nielen, M. M. J. (2021) · Open Heart · doi:10.1136/openhrt-2020-001459 · Cited by 49
O’Sullivan, J. W., Shcherbina, A., Justesen, J. M., Turakhia, M. P., Perez, M. V., Wand, H., Tcheandjieu, C., Clarke, S. L., Harrington, R. A., Rivas, M. A., et al. (2021) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.120.003168 · Cited by 54
Erratum: Global epidemiology of atrial fibrillation
Rahman, F., Kwan, G. F., & Benjamin, E. J. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.114 · Cited by 55
Serum Uric Acid and Risk of Left Atrial Thrombus in Patients With Nonvalvular Atrial Fibrillation
Tang, R., Dong, J., Yan, X., Du, X., Kang, J.-P., Wu, J., Yu, R., Long, D., Ning, M., Sang, C., et al. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.06.009 · Cited by 53
Badheka, A. O., Rathod, A. D., Kizilbash, M. A., Bhardwaj, A., Ali, O. A., Afonso, L., & Jacob, S. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.06.045 · Cited by 54
LaHaye, S. A., Gibbens, S. L., Ball, D. G. A., Day, A. G., Olesen, J. B., & Skanes, A. C. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs167 · Cited by 50
Bushnell, C., & McCullough, L. D. (2014) · Annals of Internal Medicine · doi:10.7326/m14-0762 · Cited by 53
Yoon, C.-Y., Noh, J., Jhee, J. H., Chang, T. I., Kang, E. W., Kee, Y. K., Kim, H., Park, S., Yun, H., Jung, S.-Y., et al. (2017) · Stroke · doi:10.1161/strokeaha.117.017114 · Cited by 53
Overview of oral antithrombotic treatment in elderly patients with atrial fibrillation
Kato, E. T., Goto, S., & Giugliano, R. P. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.10.006 · Cited by 53
Postoperative atrial fibrillation is associated with higher scores on predictive indices
Burgos, L. M., Seoane, L., Parodi, J. B., Espinoza, J., Brito, V. G., Benzadón, M., & Navia, D. (2018) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2018.10.091 · Cited by 53
Atrial fibrillation and frailty.
Guo, Q., Du, X., & Ma, C. (2020) · PubMed Central · doi:10.11909/j.issn.1671-5411.2020.02.007 · Cited by 53
Reese‐Petersen, A. L., Olesen, M. S., Karsdal, M. A., Svendsen, J. H., & Genovese, F. (2020) · Matrix Biology · doi:10.1016/j.matbio.2020.03.005 · Cited by 53
Catheter Ablation for Atrial Fibrillation in Patients With Concurrent Heart Failure
Arora, S., Jaswaney, R., Jani, C., Zuzek, Z., Thakkar, S. J., Patel, H., Patel, M., Patel, N., Tripathi, B., Lahewala, S., et al. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.09.035 · Cited by 53
Svendsen, J. H., Nielsen, J. C., Darkner, S., Jensen, G. V. H., Mortensen, L. S., Andersen, H. R., & on behalf of the DANPACE Investigators (2013) · Heart · doi:10.1136/heartjnl-2013-303695 · Cited by 49
Agnelli, G., & Paciaroni, M. (2014) · Thrombosis and Haemostasis · doi:10.1160/th13-08-0667 · Cited by 52
Jiao, M., Liu, C., Liu, Y., Wang, Y., Gao, Q., & Ma, A. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1137230 · Cited by 52
Andersen, S. D., Gorst‐Rasmussen, A., Lip, G. Y. H., Bach, F. W., & Larsen, T. B. (2015) · Stroke · doi:10.1161/strokeaha.115.009912 · Cited by 53
Self-citationPrevalence of atrial fibrillation in Asia and the world
Kodani, E., & Atarashi, H. (2012) · Journal of Arrhythmia · doi:10.1016/j.joa.2012.07.001 · Cited by 53
Lip, G. Y. H., Al‐Khatib, S. M., Cosío, F. G., Banerjee, A., Savelieva, I., Ruskin, J. N., Blendea, D. C., Nattel, S., Bono, J. D., Conroy, J., et al. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001179 · Cited by 56
Self-citationDodson, J. A., Petrone, A. B., GAGNON, D. R., Tinetti, M. E., Krumholz, H. M., & Gaziano, J. M. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2015.0345 · Cited by 52
Thromboembolic Events in Paroxysmal vs. Permanent Non-Valvular Atrial Fibrillation
Inoue, H., Atarashi, H., Okumura, K., Yamashita, T., Kumagai, N., Origasa, H., & for the J-RHYTHM Registry Investigators (2014) · Circulation Journal · doi:10.1253/circj.cj-14-0507 · Cited by 52
Ophthalmic patients on antithrombotic drugs: a review and guide to perioperative management
Kong, K.-L., & Khan, J. C. (2014) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2014-306036 · Cited by 52
Asian strategy for stroke prevention in atrial fibrillation
Chiang, C., Wang, K.-L., & Lin, S. (2015) · EP Europace · doi:10.1093/europace/euv231 · Cited by 52
Wang, Y., Singh, S., & Bajorek, B. V. (2016) · Pharmacy Practice · doi:10.18549/pharmpract.2016.02.706 · Cited by 52
Burden of preoperative atrial fibrillation in patients undergoing coronary artery bypass grafting
Malaisrie, S. C., McCarthy, P. M., Kruse, J. T., Matsouaka, R., Andrei, A., Grau‐Sepulveda, M. V., Friedman, D. J., Cox, J. L., & Brennan, J. M. (2018) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2018.01.069 · Cited by 52
Verheugt, F. W. A., Gao, H., Almahmeed, W. A., Ambrosio, G., Angchaisuksiri, P., Atar, D., Bassand, J., Camm, A. J., Cools, F. J. S., Eikelboom, J. W., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx730 · Cited by 53
Kosich, F., Schumacher, K., Potpara, T., Lip, G. Y. H., Hindricks, G., & Kornej, J. (2019) · Clinical Cardiology · doi:10.1002/clc.23139 · Cited by 52
Self-citationHuang, H., Liu, P. P., Hsu, J., Lin, S., Peng, C. C., Wang, J., & Loh, C. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz952 · Cited by 52
Hanon, O., Vidal, J., Pisica–Donose, G., Orvoën, G., David, J., Chaussade, E., Caillard, L. K., de Jong, L. W., Boulloche, N., Vinsonneau, U., et al. (2020) · Heart · doi:10.1136/heartjnl-2020-317923 · Cited by 52
Proietti, M., Vitolo, M., Harrison, S. L., Lane, D. A., Fauchier, L., Marín, F. R., Näbauer, M., Potpara, T., Dan, G., Boriani, G., et al. (2021) · Clinical Research in Cardiology · doi:10.1007/s00392-021-01914-y · Cited by 52
Self-citationLévy, S., Steinbeck, G., Santini, L., Näbauer, M., Penela, D., Kantharia, B. K., Saksena, S. V., & Cappato, R. (2022) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-022-01195-z · Cited by 52
Pisters, R., van Oostenbrugge, R. J., Knottnerus, I. L. H., de Vos, C. B., Boreas, A., Lodder, J., Prins, M. H., Crijns, H. J. G. M., & Tieleman, R. G. (2010) · EP Europace · doi:10.1093/europace/euq080 · Cited by 52
Self-citationKomen, J. J., Pottegård, A., Mantel-Teeuwisse, A. K., Forslund, T., Hjemdahl, P., Wettermark, B., Hallas, J., Olesen, M. S., Bennie, M., Mueller, T., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac111 · Cited by 51
Therapy for Atrial Fibrillation in Patients with Drug-Eluting Stents
Lee, S., Yu, H. T., Lee, Y., Lee, S., Heo, J. H., Ahn, S. G., Shin, S., Doh, J., Her, A., Cho, B. R., et al. (2025) · New England Journal of Medicine · doi:10.1056/nejmoa2512091 · Cited by 51
Cha, M.-J., Kim, Y. D., Nam, H. S., Kim, J., Lee, D. H., & Heo, J. H. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03547.x · Cited by 51
Dobesh, P. P., & Fanikos, J. R. (2015) · Drugs · doi:10.1007/s40265-015-0452-4 · Cited by 51
Predicting postoperative atrial fibrillation using CHA2DS2-VASc scores
Kashani, R. G., Sareh, S., Genovese, B., Hershey, C., Rezentes, C., Shemin, R. J., Buch, E. F., & Benharash, P. (2015) · Journal of Surgical Research · doi:10.1016/j.jss.2015.04.047 · Cited by 51
Berlin, S., Trybush, S., Fogelqvist, J., Gyllenstrand, N., Hallingbäck, H. R., Åhman, I. M., Nordh, N., Shield, I. F., Powers, S. J., Weih, M., et al. (2014) · Tree Genetics & Genomes · doi:10.1007/s11295-014-0782-5 · Cited by 51
McGrath, E. R., Kapral, M. K., Fang, J., Eikelboom, J. W., Conghaile, A. Ó., Canavan, M. D., & O'Donnell, M. J. (2012) · Stroke · doi:10.1161/strokeaha.112.654145 · Cited by 52
Briffa, T. G., Hung, J., Knuiman, M. W., McQuillan, B., Chew, D. P., Eikelboom, J. W., Hankey, G. J., Teng, T. K., Nedkoff, L., Weerasooriya, R., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.01.196 · Cited by 51
Vanbeselaere, V., Truyers, C., Elli, S., Buntinx, F., Witte, H. D., Degryse, J., Henrard, S., & Vaes, B. (2016) · BMC Cardiovascular Disorders · doi:10.1186/s12872-016-0235-1 · Cited by 51
Fangel, M. V., Nielsen, P. B., Kristensen, J. K., Larsen, T. B., Overvad, T. F., Lip, G. Y. H., & Jensen, M. B. (2019) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.118.007030 · Cited by 49
Self-citation
Metadata
- Authors
- Lip, G. Y. H., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. G. M.
- Affiliations
- Birmingham City Hospital (GB)
- Maastricht University Medical Centre (NL)
- Corresponding author
- Lip, Gregory Y.H.
- Venue
- Chest
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 137
- Issue
- 2
- Pages
- 263-272
- ISSN
- 0012-3692 (ISSN-L)
- OpenAlex
- W2162586165
- Cited by
- 6,879
- References
- 34
- Citations by year
- 2026: 276 · 2025: 362 · 2024: 419 · 2023: 466 · 2022: 524 · 2021: 590 · 2020: 538 · 2019: 476 · 2018: 507 · 2017: 471 · 2016: 495 · 2015: 474 · 2014: 400 · 2013: 337 · 2012: 304
- FWCI
- 115.14
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- CHEST Journal (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Research Publications (Maastricht University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Keywords
- atrial fibrillation, stroke risk stratification, thromboembolism, CHA2DS2-VASc score, CHADS2 score, risk prediction, risk reclassification
- MeSH terms
- Aged, Atrial Fibrillation, Europe, Female, Follow-Up Studies, Humans, Male, Population Surveillance, Prognosis, Retrospective Studies, Risk Factors, Thromboembolism, Reproducibility of Results, Incidence, Risk Assessment, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.